CN101386605A - 非布司他新型晶体及其制备方法 - Google Patents
非布司他新型晶体及其制备方法 Download PDFInfo
- Publication number
- CN101386605A CN101386605A CNA2008102016526A CN200810201652A CN101386605A CN 101386605 A CN101386605 A CN 101386605A CN A2008102016526 A CNA2008102016526 A CN A2008102016526A CN 200810201652 A CN200810201652 A CN 200810201652A CN 101386605 A CN101386605 A CN 101386605A
- Authority
- CN
- China
- Prior art keywords
- crystal
- crystal form
- febustat
- solvent
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
图1中峰序号 | 2θ(°) | I/I0(%) |
3 | 5.64±0.2 | 94.96 |
2 | 7.80±0.2 | 95.80 |
7 | 11.38±0.2 | 33.61 |
4 | 11.70±0.2 | 52.10 |
1 | 12.54±0.2 | 100 |
5 | 12.74±0.2 | 49.58 |
8 | 17.18±0.2 | 31.93 |
6 | 26.12±0.2 | 36.97 |
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2008102016526A CN101386605B (zh) | 2008-10-23 | 2008-10-23 | 非布司他新型晶体及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2008102016526A CN101386605B (zh) | 2008-10-23 | 2008-10-23 | 非布司他新型晶体及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101386605A true CN101386605A (zh) | 2009-03-18 |
CN101386605B CN101386605B (zh) | 2010-09-08 |
Family
ID=40476301
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2008102016526A Expired - Fee Related CN101386605B (zh) | 2008-10-23 | 2008-10-23 | 非布司他新型晶体及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101386605B (zh) |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101817801A (zh) * | 2009-08-12 | 2010-09-01 | 北京红惠新医药科技有限公司 | 2-(3-氰基-4-异丁氧基苯基)-4-甲基-5-噻唑甲酸新晶型k及其他晶型的制备方法 |
CN101824005A (zh) * | 2010-04-27 | 2010-09-08 | 上海凯米侬医药科技有限公司 | 一种非布索坦的新晶型q及其制备方法 |
WO2010144685A1 (en) | 2009-06-10 | 2010-12-16 | Teva Pharmaceutical Industries Ltd. | Crystalline forms of febuxostat |
WO2011080651A2 (en) | 2009-12-31 | 2011-07-07 | Ranbaxy Laboratories Limited | Polymorphic forms of febuxostat |
WO2011107911A1 (en) | 2010-03-04 | 2011-09-09 | Ranbaxy Laboratories Limited | Polymorph of 2-[3-cyano-4-(2-methylpropoxy)phenyl]-4-methylthiazole-5-carboxylic acid |
WO2012020272A2 (en) | 2010-08-13 | 2012-02-16 | EGIS GYÓGYSZERGYÁR Nyilvánosan Müködö Részvénytársaság | New salts, polymorphs and solvates of a pharmaceutical active ingredient |
WO2013088449A1 (en) | 2011-12-16 | 2013-06-20 | Natco Pharma Limited | Stable crystal form of febuxostat and process for the preparation thereof |
CN103396378A (zh) * | 2013-07-29 | 2013-11-20 | 杭州朱养心药业有限公司 | 稳定的非布司他结晶 |
CN104114545A (zh) * | 2011-11-15 | 2014-10-22 | 迈兰实验室有限公司 | 用于制备非布索坦多晶型物的方法 |
WO2016091230A1 (en) | 2014-12-12 | 2016-06-16 | Zentiva, K.S. | Formulations containing a solid solution of febuxostat |
CN107540630A (zh) * | 2016-06-29 | 2018-01-05 | 康普药业股份有限公司 | 一种非布司他化合物及制备方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ID21775A (id) * | 1996-10-25 | 1999-07-22 | Yoshitomi Pharmaceutical | Senyawa-senyawa 1-fenilpirazol dan penggunaan farmasinya |
PT1956014T (pt) * | 1998-06-19 | 2019-04-24 | Teijin Pharma Ltd | Polimorfos de ácido 2-(3-ciano-4-isobutiloxifenil)-4-metil- 5-tiazolecarboxílico e método para a sua produção |
DK1488790T3 (da) * | 2002-03-28 | 2014-10-13 | Teijin Pharma Ltd | Fast præparat indeholdende en enkeltkrystalform A af etthiazolcarboxylsyrederivat |
CN101139325B (zh) * | 2006-09-07 | 2010-05-12 | 上海医药工业研究院 | 2-(3-氰基-4-异丁氧基苯基)-4-甲基-5-噻唑甲酸晶型及其制备方法 |
CN1970547B (zh) * | 2006-12-07 | 2011-04-06 | 重庆医药工业研究院有限责任公司 | 非布司他的晶型及其制备方法 |
-
2008
- 2008-10-23 CN CN2008102016526A patent/CN101386605B/zh not_active Expired - Fee Related
Cited By (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8742129B2 (en) | 2009-06-10 | 2014-06-03 | Teva Pharmaceutical Industries Ltd. | Crystalline forms of febuxostat |
EP2532654A1 (en) | 2009-06-10 | 2012-12-12 | Teva Pharmaceutical Industries Ltd. | Crystalline forms of febuxostat |
US8415481B2 (en) | 2009-06-10 | 2013-04-09 | Teva Pharmaceuticals Usa, Inc. | Crystalline form of febuxostat |
US8609856B2 (en) | 2009-06-10 | 2013-12-17 | Teva Pharmaceuticals Usa, Inc. | Crystalline forms of Febuxostat |
JP2012529537A (ja) * | 2009-06-10 | 2012-11-22 | テバ ファーマシューティカル インダストリーズ リミティド | フェブキソスタットの結晶形 |
DE202010017868U1 (de) | 2009-06-10 | 2012-11-28 | Teva Pharmaceutical Industries Ltd. | Kristalline Formen von Febuxostat |
CN102803240A (zh) * | 2009-06-10 | 2012-11-28 | 特瓦制药工业有限公司 | 非布索坦的晶形 |
WO2010144685A1 (en) | 2009-06-10 | 2010-12-16 | Teva Pharmaceutical Industries Ltd. | Crystalline forms of febuxostat |
CN101817801A (zh) * | 2009-08-12 | 2010-09-01 | 北京红惠新医药科技有限公司 | 2-(3-氰基-4-异丁氧基苯基)-4-甲基-5-噻唑甲酸新晶型k及其他晶型的制备方法 |
WO2011080651A2 (en) | 2009-12-31 | 2011-07-07 | Ranbaxy Laboratories Limited | Polymorphic forms of febuxostat |
WO2011107911A1 (en) | 2010-03-04 | 2011-09-09 | Ranbaxy Laboratories Limited | Polymorph of 2-[3-cyano-4-(2-methylpropoxy)phenyl]-4-methylthiazole-5-carboxylic acid |
CN101824005B (zh) * | 2010-04-27 | 2012-06-27 | 上海凯米侬医药科技有限公司 | 一种非布索坦的晶型q及其制备方法 |
CN101824005A (zh) * | 2010-04-27 | 2010-09-08 | 上海凯米侬医药科技有限公司 | 一种非布索坦的新晶型q及其制备方法 |
WO2012020272A2 (en) | 2010-08-13 | 2012-02-16 | EGIS GYÓGYSZERGYÁR Nyilvánosan Müködö Részvénytársaság | New salts, polymorphs and solvates of a pharmaceutical active ingredient |
CN104114545A (zh) * | 2011-11-15 | 2014-10-22 | 迈兰实验室有限公司 | 用于制备非布索坦多晶型物的方法 |
JP2014533297A (ja) * | 2011-11-15 | 2014-12-11 | マイラン ラボラトリーズ リミテッドMylan Laboratories Limited | フェブキソスタットの多形の調製方法 |
WO2013088449A1 (en) | 2011-12-16 | 2013-06-20 | Natco Pharma Limited | Stable crystal form of febuxostat and process for the preparation thereof |
CN103396378A (zh) * | 2013-07-29 | 2013-11-20 | 杭州朱养心药业有限公司 | 稳定的非布司他结晶 |
CN103396378B (zh) * | 2013-07-29 | 2015-06-10 | 杭州朱养心药业有限公司 | 非布司他结晶 |
WO2016091230A1 (en) | 2014-12-12 | 2016-06-16 | Zentiva, K.S. | Formulations containing a solid solution of febuxostat |
CN107540630A (zh) * | 2016-06-29 | 2018-01-05 | 康普药业股份有限公司 | 一种非布司他化合物及制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN101386605B (zh) | 2010-09-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101386605B (zh) | 非布司他新型晶体及其制备方法 | |
RU2631321C2 (ru) | Кристаллическая форма i дималеата ингибитора тирозинкиназы и способ ее получения | |
CN110483486B (zh) | 一种奥西替尼酮咯酸盐晶型及其制备方法 | |
CN102731512A (zh) | 一种鲁拉西酮中间体及鲁拉西酮的制备方法 | |
CN108727263A (zh) | 硫酸羟氯喹晶型a及其制备方法 | |
US11420942B2 (en) | Crystalline forms of [3-(4- {2-butyl-1-[4-(4-chloro-phenoxy)-phenyl]-1H-imidazol-4-yl} -phenoxy)-propyl]-diethyl-amine | |
WO2016131431A1 (en) | Solid forms of empagliflozin | |
WO2009137714A2 (en) | Forms of lapatinib ditosylate and processes for preparation thereof | |
CN105175340A (zh) | 一种用高纯度中间体晶体制备高纯度盐酸右美托咪定晶体的方法 | |
CN110041261A (zh) | 一种盐酸萘甲唑啉的制备方法 | |
CN103664659B (zh) | 一种盐酸达泊西汀晶型及其制备方法 | |
CN101774958B (zh) | N-正丙基-3-(4-甲基苯基)-4-(4-甲磺酰基苯基)-2,5-二氢吡咯-2-酮的i型结晶及其制造方法 | |
CN103864690B (zh) | 伊伐布雷定盐酸盐的s晶型、其制备方法和药物组合物 | |
CN105503854A (zh) | 一种达沙替尼无水合物的新晶型物及其制备方法 | |
CN111320632B (zh) | 盐酸咪达唑仑的新晶型及其制备方法 | |
AU2005227745A1 (en) | Crystalline pyrazole derivative | |
CA3010315A1 (en) | Crystalline forms of thienopyrimidine compound | |
CN100548998C (zh) | 马来酸桂哌齐特晶型及其制备方法 | |
CN102070616B (zh) | 一种制备伏立康唑晶型b的方法 | |
CN104326927B (zh) | 一种1-[2-氨基-1-(4-甲氧基苯基)乙基]环己醇硫酸盐的制备方法 | |
CN103396370B (zh) | 一种安立生坦的纯化方法 | |
CN112707829B (zh) | 一种妥洛特罗晶型及制备方法 | |
CN109796400A (zh) | 一种甲苯磺酸索拉菲尼晶型及其制备方法 | |
CN114075109B (zh) | 一种氟比洛芬酯的制备方法及制备的晶型 | |
CN102321141A (zh) | 一种17α-乙酰氧基-11β-(4-N,N-二甲氨基苯基)-19-去甲孕甾-4,9-二烯-3,20-二酮的无定形物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee | ||
CP01 | Change in the name or title of a patent holder |
Address after: 200031 No. 294, Taiyuan Road, Shanghai Patentee after: Shanghai Institute of Materia Medica, Chinese Academy of Sciences Patentee after: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Address before: 200031 No. 294, Taiyuan Road, Shanghai Patentee before: Shanghai Institute of Materia Medica, Chinese Academy of Sciences Patentee before: Jiangsu Chiatai Tianqing Pharmaceutical Co., Ltd. |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20100908 Termination date: 20181023 |